Skip navigation
Skip navigation

Effects of switching from ranibizumab to aflibercept in eyes with exudative age-related macular degeneration

Barthelmes, Daniel; Campain, Anna; Nguyen, Phuc; Arnold, Jennifer J; McAllister, Ian L; Simpson, Judy M; Hunyor, Alex P; Guymer, Robyn; Essex, Rohan; Morlet, Nigel; Gillies, MC


Aims To examine 12-month outcomes of eyes switching from intravitreal ranibizumab to aflibercept for neovascular age-related macular degeneration (nAMD). Methods Database observational study of eyes with nAMD tracked by the Fight Retinal Blindness outcome registry that received ranibizumab for at least 12 months before switching to aflibercept and followed for at least 12 months after the switch. Visual acuity (VA) recorded at 12 months after the switch was analysed using locally weighted...[Show more]

CollectionsANU Research Publications
Date published: 2016
Type: Journal article
Source: British Journal of Ophthalmology
DOI: 10.1136/bjophthalmol-2015-308090


File Description SizeFormat Image
01_Barthelmes_Effects_of_switching_from_2016.pdf306.22 kBAdobe PDF    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  17 November 2022/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator